IBA1 immunoreactivity was similar in all WT and AD groups despite a non-significant decrease of 21.6% in IBA1 expression in viniferin-treated AD mice compared to resveratrol-treated AD mice (Figure 2C). The gene discussed is AIF1; the disease is Alzheimer disease.